07.07.2013 Views

Richard E. Smalley Institute for Nanoscale Science and - Center for ...

Richard E. Smalley Institute for Nanoscale Science and - Center for ...

Richard E. Smalley Institute for Nanoscale Science and - Center for ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Rebecca <strong>Richard</strong>s-Kortum<br />

Rebekah Drezek<br />

Sibani Lisa Biswal<br />

16<br />

World Health<br />

Professor <strong>Richard</strong>s-Kortum focuses on<br />

translating research that integrates advances<br />

in nanotechnology <strong>and</strong> molecular<br />

imaging with microfabrication technologies<br />

to develop optical imaging systems<br />

that are inexpensive <strong>and</strong> provide point-ofcare<br />

diagnosis. When used with contrast<br />

agents, these rugged <strong>and</strong> portable optical<br />

imaging systems detect molecular signatures<br />

of precancer, assess tumor margins<br />

<strong>and</strong> monitor a patient’s response to therapy.<br />

Over the past few years, <strong>Richard</strong>s-<br />

Kortum <strong>and</strong> collaborators have translated<br />

these technologies from North America to<br />

both low- <strong>and</strong> medium-resource developing<br />

countries (Botswana, India, Taiwan,<br />

Mexico <strong>and</strong> Brazil).<br />

Professor Rebekah Drezek conducts basic,<br />

applied <strong>and</strong> translational research at<br />

the interface of photonics, medicine <strong>and</strong><br />

nanotechnology toward the development of<br />

cost-effective, optically based strategies <strong>for</strong><br />

screening, diagnosis <strong>and</strong> monitoring of cancer<br />

with particular emphasis on novel technologies<br />

to improve women’s health care.<br />

Recently Drezek was awarded a grant to<br />

combine the advantages of immunotherapy<br />

<strong>and</strong> light-activated photothermal therapy in<br />

the detection <strong>and</strong> treatment of cancer.<br />

Assistant Professor Sibani Lisa Biswal is<br />

working with MD Anderson Cancer <strong>Center</strong><br />

researchers to improve disease screening<br />

in patients through a new technology of<br />

programmable nanodroplet chemistry. This<br />

sensor technology detects the way proteins<br />

are folded to assess disease states.<br />

Using nanotechnology <strong>and</strong> microfluidics,<br />

this sensor offers a cost-effective way to<br />

test <strong>for</strong> a variety of variables quickly <strong>and</strong><br />

efficiently.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!